Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONC-14004250Phase 4Completed
Phase 4, open-label, single-arm trial of dexmedetomidine in Cardiovascular Malformation (CVM), sponsored by Guangzhou Women and Children's Medical Centre. Primary endpoints: Onset time, Wake up time and 1 more. Started May 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONC-14004250.